Non-invasive Measures of Distal Lung Disease in Asthmatics

Teva Pharmaceuticals

Status and phase: Completed; Phase 4

Conditions: Asthma

Treatments: Drug: QVAR; Drug: Servent Diskus; Drug: Advair

Study type: Interventional

Funder types: Industry

Identifiers

NCT00250341

IXR-403-4-196

Details and patient eligibility

About

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

Full description

The study consists of 3 phases. There are 7 study visits.

Enrollment: 34 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18-65 years old
• Currently using SABA prn or a low-to-moderate persistent asthma

Exclusion criteria

• Tobacco use within 1 year or >= 5 pack years

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

34 participants in 2 patient groups

Advair

Active Comparator group

Treatment:

Drug: Advair

QVAR

Experimental group

Treatment:

Drug: Servent Diskus

Drug: QVAR